A prospective, Single-Centre study to investigate the plaque characteristics of lesions in young Indian patients of =40 years
- Conditions
- Health Condition 1: I248- Other forms of acute ischemic heart disease
- Registration Number
- CTRI/2024/01/061165
- Lead Sponsor
- Dr Nityanand Tripathi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patient is = 18 and = 40 years of age and going for PCI of the culprit lesion (more than 90 % diameter stenosis)
2. At least =1 de novo lesions in a native coronary segment with a visually estimated diameter stenosis between = 40 % and < 90%
3. Patient has documented ACS (unstable angina, NSTEMI or STEMI within the previous 72 hours)
4. Patient demonstrates a left ventricular ejection fraction (LVEF) of = 40% as measured prior to enrolment
5. Patient understands and agrees to comply with all specified study requirements and provides written Informed Consent to this effect
1) Patients with a medical condition that limits the life expectancy to 1 years or less
2) Patients scheduled to undergo surgery within 3 months that requires interruption of DAPT
3) Women who are pregnant or planning to be pregnant
4) Patients with allergy to contrast agents
5) Patients with coronary artery occlusion occurring at a site where a stent has already been placed or in whom observation by OCT is considered difficult
6) Patients in shock
7) Patients with a history of adverse reactions to aspirin, clopidogrel, or prasugrel
8) Patients who are ineligible for the study in the opinion of the investigator
9) Patients in whom follow-up at 12 months after the index procedure is considered difficult
10) Patients with renal failure with a serum creatinine level of 2.0 mg/dL or more at presentation (non-HD patients)
11) Patients with active heart failure
12) Patients with acute Mitral regurgitation.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plaque CharacteristicsTimepoint: Baseline and 1 year
- Secondary Outcome Measures
Name Time Method Incidence of MACE, a composite of Cardiac <br/ ><br>Death, MI or re-hospitalization for progressive <br/ ><br>anginaTimepoint: Day 30, 6 and 12 months